CA Stock MarketDetailed Quotes
DOCT Beyond Medical Technologies Inc
- 0.030
- 0.0000.00%
15min DelayMarket Closed Nov 12 13:25 ET
237.42KMarket Cap-500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.030Pre Close0.00Turnover0.05552wk High0.00%Turnover Ratio7.91MShares0.03052wk Low-0.06EPS TTM237.42KFloat Cap236.000Historical HighLossP/E (Static)7.91MShs Float0.030Historical Low-0.08EPS LYR0.00%Amplitude--Dividend TTM-0.55P/B1Lot Size--Div YieldTTM
Beyond Medical Technologies Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 52.16%-36.31K | 86.28%-30.77K | 18.95%-500.63K | -131.81%-105.06K | 75.23%-95.4K | 48.12%-75.9K | 46.15%-224.27K | 71.46%-617.67K | 134.09%330.25K | -993.00%-385.14K |
| Net income from continuing operations | 65.05%-36.78K | 52.16%-64.5K | 33.90%-552K | -271.19%-211.63K | 64.46%-100.3K | 51.20%-105.24K | 70.75%-134.83K | 71.33%-835.11K | 108.80%123.63K | 7.02%-282.2K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.02K | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -38.83%122.55K | --0 | --0 |
| Change In working capital | 173.77%80.32K | 137.71%33.73K | -44.68%51.38K | -47.91%106.58K | 104.76%4.9K | -57.69%29.34K | -14.48%-89.45K | -29.44%92.88K | 4.85%204.6K | -152.67%-102.94K |
| -Change in receivables | 105.02%124 | -26.92%-891 | -74.60%3.19K | 280.75%3.97K | -37.42%2.39K | -128.12%-2.47K | -132.38%-702 | 699.05%12.57K | -128.65%-2.2K | -48.13%3.82K |
| -Change in prepaid assets | --0 | --0 | -93.18%905 | -98.02%263 | 173.25%2.1K | 59.23%7.82K | -354.34%-9.27K | -57.41%13.27K | 411.01%13.27K | -104.62%-2.87K |
| -Change in payables and accrued expense | 234.27%80.19K | 143.57%34.62K | -29.47%47.28K | -49.23%102.35K | 100.37%413 | -56.90%23.99K | -1.55%-79.47K | -34.63%67.03K | 1,605.01%201.6K | -215.33%-111.96K |
| Cash from discontinued investing activities | 100.21%147 | -57.21%-15.15K | 91.99%-26.42K | 109.27%53.27K | -100.47%-907 | -1,380.21%-69.14K | -120.61%-9.63K | -143.07%-329.62K | -574.88K | 193.11K |
| Operating cash flow | 75.07%-36.16K | 80.37%-45.91K | 44.36%-527.04K | 78.83%-51.79K | 49.85%-96.31K | -2.94%-145.05K | 36.73%-233.91K | 32.29%-947.29K | -20.17%-244.63K | -444.98%-192.03K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 30K | 30K | 0 | 0 | 0 | ||||
| Net issuance payments of debt | --0 | --30K | --30K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | -27.69K | |||||||||
| Financing cash flow | --0 | --30K | --30K | -57.46%30K | --0 | --0 | --0 | --0 | 649.65%70.51K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -84.08%48.23K | -88.05%64.14K | -62.48%536.75K | -90.65%61.49K | -82.01%157.8K | -70.88%302.85K | -62.48%536.75K | 129.21%1.43M | -60.05%657.59K | -48.56%877.31K |
| Current changes in cash | 75.07%-36.16K | 93.20%-15.91K | 47.53%-497.04K | 87.49%-21.79K | 56.17%-96.31K | 10.82%-145.05K | 40.15%-233.91K | -217.45%-947.29K | 19.17%-174.12K | -270.43%-219.72K |
| Cash adjustments other than cash changes | ---- | ---- | -54.15%24.43K | ---- | ---- | ---- | ---- | --53.28K | ---- | ---- |
| End cash Position | -92.36%12.06K | -84.08%48.23K | -88.05%64.14K | -88.05%64.14K | -90.65%61.49K | -82.01%157.8K | -70.88%302.85K | -62.48%536.75K | -62.48%536.75K | -60.05%657.59K |
| Free cash from | 75.07%-36.16K | 80.37%-45.91K | 44.36%-527.04K | 78.83%-51.79K | 49.85%-96.31K | -2.94%-145.05K | 36.73%-233.91K | 32.29%-947.29K | -80.43%-244.63K | -444.94%-192.03K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data